U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: January 7-13, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: January 7-13, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 01/07/2024
Location: San Francisco, CA
Subject: 2024 Centers of Excellence in Regulatory Science and Innovation (CERSI) Innovations in Regulatory Science Summit
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, and other invited guests

Event Date: 01/08/2024
Location: San Francisco, CA
Subject: The Biotech CEO Sisterhood / The Reagan-Udall Foundation for the FDA Luncheon
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from several biotech and pharmaceutical companies interested in biopharma

Event Date: 01/08/2024
Location: Virtual
Subject: FDA's First Approval for Mass Drug Imports from Canada
FDA Participant/Group: ANDREW ZACHER; KIMBERLEE TRZECIAK;
Non FDA Participant/Group: Greg Loyst, Linsey Hollett, Pamela Aung-Thin, Stefania Trombetti (Health Canada);

Event Date: 01/10/2024
Location: Las Vegas, NV
Subject: Consumer Technology Association Conference
FDA Participant/Group: MICHAEL FELBERBAUM;
Non FDA Participant/Group: Industry, government, academia, media, and other registered participants

Event Date: 01/12/2024
Location: Virtual
Subject: Safety of and Research on Puberty-Delaying Medicines
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Erika Miller, Grace Kranstover (CRD Associates); Joshua Safer (Mount Sinai Center for Transgender Medicine and Surgery); Mila Becker (Endocrine Society);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 01/07/2024
Location: Virtual
Subject: 2024 Centers of Excellence in Regulatory Science and Innovation (CERSI) Innovations in Regulatory Science Summit
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, and other invited guests

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 01/08/2024
Location: College Park, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: KRISTI MULDOON JACOBS; SUZANNE ROOSEN; STEVEN MUSSER; LAUREN FINNEGAN; KARI BARRETT; GIRVIN LIGGANS;
Non FDA Participant/Group: Alex Eapen, Chris Forgues, Emily Dimiero, Lea Buerman, Sean Leighton, Susan Blum (Cargill);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 01/09/2024
Location: Virtual
Subject: Member State Mechanism on Substandard and Falsified Medicines Meeting
FDA Participant/Group: RUSSELL CAMPBELL, JOSEPH RIERAS, RAVI BHARWANI, JESSICA STEWART
Non FDA Participant/Group: Hiiti Sillo, Leticia Lastra, Rutendo Kuwana (World Health Organization);

Event Date: 01/12/2024
Location: Virtual
Subject: Steering Committee of the Member State Mechanism on Substandard and Falsified Medical Products Meeting
FDA Participant/Group: RUSSELL CAMPBELL, MICAH AUGUSMA
Non FDA Participant/Group: Members of the Steering Committee of the Member State Mechanism on Substandard and Falsified Medical Products

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 01/07/2024
Location: San Francisco, CA
Subject: 2024 Centers of Excellence in Regulatory Science and Innovation (CERSI) Innovations in Regulatory Science Summit
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, and other invited guests

Event Date: 01/07/2024
Location: San Francisco, CA
Subject: Wing at J.P. Morgan 2024; Healthcare Keynote Roundtable
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and other stakeholders

Event Date: 01/08/2024
Location: San Francisco, CA
Subject: The Biotech CEO Sisterhood / The Reagan-Udall Foundation for the FDA Luncheon
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from several biotech and pharmaceutical companies interested in biopharma

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 01/07/2024
Location: Virtual
Subject: 2024 Centers of Excellence in Regulatory Science and Innovation (CERSI) Innovations in Regulatory Science Summit
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, and other invited guests

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/07/2024
Location: San Francisco, CA
Subject: 2024 Centers of Excellence in Regulatory Science and Innovation (CERSI) Innovations in Regulatory Science Summit
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, and other invited guests

Event Date: 01/08/2024
Location: San Francisco, CA
Subject: STAT@JPM (J. P. Morgan) - What’s Next in Biotech?; Gene Therapy Conversation
FDA Participant/Group: N/A
Non FDA Participant/Group: Research, academic, industry, and regulatory stakeholders

Event Date: 01/08/2024
Location: San Francisco, CA
Subject: Alliance for Regenerative Medicine’s Cell and Gene State of the Industry Briefing; Breaking Through the Barriers to Cell and Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academic, and patient stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 01/07/2024
Location: Virtual
Subject: 2024 Centers of Excellence in Regulatory Science and Innovation (CERSI) Innovations in Regulatory Science Summit
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, and other invited guests

Event Date: 01/11/2024
Location: Silver Spring, MD
Subject: Status Updates
FDA Participant/Group: COURTNEY LIAS; KEISHA THOMAS; KELLIE KELM;
Non FDA Participant/Group: Boris Shkolnik, Marcus Gesner, Pierre Boisier, Stefan Kaufmann, Todd Brill (Olympus Corporation);

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 01/10/2024
Location: Virtual
Subject: Premarket Tobacco Product Application (PMTA) Updates and Enforcement Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff from House Committee on Oversight and Accountability (HOA)

Event Date: 01/12/2024
Location: Virtual
Subject: Tobacco Enforcement
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff from the Senate Committee on Health, Education, Labor and Pensions (HELP)

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

 
Back to Top